| Active ingredient (INN) | Clonidine Transdermal System |
|---|---|
| Brand names | Clonidine Transdermal System, USP |
| ATC level 5 |
|---|
| C02AC01 |
| ATC level 4 | C02AC |
|---|
| Therapeutic category | Auto-created by FDA MedWatch — Drug Safety Alerts scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | ACTAVIS PHARMA, INC., TRUPHARMA, LLC |
|---|
| Registrations on file | 6 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Clonidine transdermal system | .1mg/d | patch | 🇺🇸 US | ACTAVIS PHARMA, INC. | Active |
| Clonidine transdermal system | .2mg/d | patch | 🇺🇸 US | ACTAVIS PHARMA, INC. | Active |
| Clonidine transdermal system | .3mg/d | patch | 🇺🇸 US | ACTAVIS PHARMA, INC. | Active |
| Clonidine Transdermal System USP | .1mg/d | patch | 🇺🇸 US | TRUPHARMA, LLC | Discontinued |
| Clonidine Transdermal System USP | .2mg/d | patch | 🇺🇸 US | TRUPHARMA, LLC | Discontinued |
| Clonidine Transdermal System USP | .3mg/d | patch | 🇺🇸 US | TRUPHARMA, LLC | Discontinued |